Staff
President, CPTxBio LLC
Dennis is an experienced scientific professional with extensive experience in the pharmaceutical and biotechnology research and development space. He has made significant preclinical and clinical contributions to over twenty biological based therapeutics, including cytokines, growth factors, and monoclonal antibodies. He has worked primarily in oncology and inflammation/auto-immune therapeutic areas.
As President of CPTxBio, Dennis provides advice, direction, and oversight on early development activities, including toxicology, pharmacokinetics, bioanalytical, and clinical pharmacology. Dennis takes an integrative approach to ensure these activities are done in an efficient and timely manner. By addressing key questions early in development, Dennis helps to build a foundation to position a product for further development and reveal important aspects of its potential.
Dennis has participated in multiple IND and ex-US regulatory filings as well as associated regulatory agency meetings (ie., Pre-IND, end of Phase 1, end of Phase 2, etc). He has participated in several BLA/NDA filings.
Dennis holds a BS degree in biochemistry from the University of Rochester, Rochester, NY and a Ph.D. in biochemistry from Utah State University, Logan Utah. He has been board certified in toxicology from the American Board of Toxicology since 1995.
You can contact Dennis at dennis@cptxbio.com.
